These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 29462225

  • 1. Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?
    Elewski BE, Cantrell W, Lin T.
    J Drugs Dermatol; 2018 Feb 01; 17(2):175-178. PubMed ID: 29462225
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes.
    Gupta AK, Korotzer A.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1260-1266. PubMed ID: 27741345
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK, Fleckman P, Baran R.
    J Am Acad Dermatol; 2000 Oct 01; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P.
    J Drugs Dermatol; 2015 Jan 01; 14(1):58-62. PubMed ID: 25607909
    [Abstract] [Full Text] [Related]

  • 10. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC, Joseph WS.
    J Drugs Dermatol; 2014 Oct 01; 13(10):1186-90. PubMed ID: 25607552
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Topical and device-based treatments for fungal infections of the toenails.
    Foley K, Gupta AK, Versteeg S, Mays R, Villanueva E, John D.
    Cochrane Database Syst Rev; 2020 Jan 16; 1(1):CD012093. PubMed ID: 31978269
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
    Elewski BE, Ghannoum MA, Mayser P, Gupta AK, Korting HC, Shouey RJ, Baker DR, Rich PA, Ling M, Hugot S, Damaj B, Nyirady J, Thangavelu K, Notter M, Parneix-Spake A, Sigurgeirsson B.
    J Eur Acad Dermatol Venereol; 2013 Mar 16; 27(3):287-94. PubMed ID: 22181693
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.